|
MOCS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.124100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.078150E-01 |
| Normal-vs-Stage2 |
7.676600E-01 |
| Normal-vs-Stage3 |
1.218610E-01 |
| Normal-vs-Stage4 |
4.670300E-02 |
| Stage1-vs-Stage2 |
2.593800E-01 |
| Stage1-vs-Stage3 |
8.520400E-01 |
| Stage1-vs-Stage4 |
2.354600E-01 |
| Stage2-vs-Stage3 |
2.546600E-01 |
| Stage2-vs-Stage4 |
9.467900E-02 |
| Stage3-vs-Stage4 |
3.347800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.131360E-01 |
| Normal-vs-AfricanAmerican |
6.253800E-01 |
| Normal-vs-Asian |
1.972640E-01 |
| Caucasian-vs-AfricanAmerican |
5.913600E-01 |
| Caucasian-vs-Asian |
8.191400E-01 |
| AfricanAmerican-vs-Asian |
5.223600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.569600E-02 |
| Normal-vs-Female |
1.262250E-01 |
| Male-vs-Female |
5.403000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.239990E-01 |
| Normal-vs-Age(41-60Yrs) |
2.285800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.754000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.341800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.643400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.408600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.796600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.005200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.438800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.714400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.749000E-01 |
| Classical-VS-Follicular |
4.879500E-03 |
| Classical-VS-Other |
2.017400E-01 |
| Classical-VS-Normal |
4.551200E-01 |
| Tall-VS-Follicular |
3.093000E-01 |
| Tall-VS-Other |
5.633200E-01 |
| Tall-VS-Normal |
1.779750E-01 |
| Follicular-VS-Other |
7.945400E-01 |
| Follicular-VS-Normal |
1.979560E-02 |
| Other-VS-Normal |
2.110600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.746770E-01 |
| Normal-vs-N1 |
1.943590E-02 |
| N0-vs-N1 |
6.368100E-02 |
|
|
